These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 23345049

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G, Chen E, Mao E, Che Z, He J.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin.
    Iwamoto T, Kagawa Y, Kojima M.
    Biol Pharm Bull; 2003 Jun; 26(6):876-9. PubMed ID: 12808304
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dosing vancomycin in the super obese: less is more.
    Crass RL, Dunn R, Hong J, Krop LC, Pai MP.
    J Antimicrob Chemother; 2018 Nov 01; 73(11):3081-3086. PubMed ID: 30203073
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
    Hirai T, Hanada K, Kanno A, Akashi M, Itoh T.
    Eur J Clin Pharmacol; 2019 Jun 01; 75(6):859-866. PubMed ID: 30770940
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E, Rule AD, Lieske JC, Kashani KB, Barreto JN, Virk A, Kuper PJ, Dierkhising RA, Leung N.
    Am J Kidney Dis; 2017 May 01; 69(5):658-666. PubMed ID: 28131530
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
    Zhang Y, Wang T, Zhang D, You H, Dong Y, Liu Y, Du Q, Sun D, Zhang T, Dong Y.
    Ther Drug Monit; 2020 Aug 01; 42(4):600-609. PubMed ID: 32097248
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Validating the Effectiveness of Switching the Vancomycin TDM Analysis Software Based on the Predictive Accuracy].
    Imai S, Yamada T, Ishiguro N, Miyamoto T, Kagami K, Tomiyama N, Niinuma Y, Nagasaki D, Suzuki K, Yamagami A, Kasashi K, Kobayashi M, Iseki K.
    Yakugaku Zasshi; 2017 Aug 01; 137(9):1185-1192. PubMed ID: 28867705
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.
    Oda K, Jono H, Kamohara H, Nishi K, Tanoue N, Saito H.
    Pharm Res; 2020 May 28; 37(6):108. PubMed ID: 32468340
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA, Ariano RE, McCrae ML, Vercaigne LM.
    Clin Infect Dis; 2012 Aug 28; 55(4):527-33. PubMed ID: 22573855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.